Catalyst Financial Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$968K Sell
2,433
-323
-12% -$141K 0.1% 125
2026
Q1
$1.27M Buy
2,756
+353
+15% +$179K 0.15% 85
2025
Q4
$1.36M Buy
2,403
+225
+10% +$120K 0.15% 71
2025
Q3
$974K Sell
2,178
-65
-3% -$31.2K 0.12% 89
2025
Q2
$1.22M Buy
2,243
+273
+14% +$143K 0.13% 65
2025
Q1
$976K Buy
1,970
+54
+3% +$29.9K 0.18% 64
2024
Q4
$1M Buy
1,916
+64
+3% +$33.3K 0.19% 64
2024
Q3
$910K Buy
1,852
+85
+5% +$39.6K 0.18% 76
2024
Q2
$786K Buy
1,767
+77
+5% +$30.7K 0.17% 76
2024
Q1
$632K Buy
1,690
+51
+3% +$19.3K 0.16% 84
2023
Q4
$553K Buy
1,639
+33
+2% +$9.84K 0.16% 86
2023
Q3
$469K Buy
1,606
+253
+19% +$79K 0.15% 99
2023
Q2
$463K Buy
1,353
+246
+22% +$74.4K 0.16% 90
2023
Q1
$283K Buy
1,107
+70
+7% +$17.2K 0.12% 131
2022
Q4
$275K Buy
+1,037
New +$253K 0.14% 120

Other funds holding ISRG

Catalyst Financial Partners's ISRG Position: Q2 2026 in Review

Catalyst Financial Partners reduced its Intuitive Surgical (ISRG) stake by 12% in Q2 2026, selling an estimated $141K and leaving 2,433 shares worth $968K. The position accounts for 0.1% of the portfolio, ranked #125.

Catalyst Financial Partners first reported a position in ISRG in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.36M in Q4 2025. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Catalyst Financial Partners held 2,433 shares of Intuitive Surgical worth $968K as of Q2 2026.
  • Catalyst Financial Partners sold 323 Intuitive Surgical shares in Q2 2026, an estimated $141K.
  • Intuitive Surgical made up 0.1% of Catalyst Financial Partners's portfolio in Q2 2026, its #125 holding.
  • Catalyst Financial Partners first reported a position in Intuitive Surgical in Q4 2022 and has held it in 15 quarters since.
  • Catalyst Financial Partners's Intuitive Surgical position peaked at $1.36M in Q4 2025.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.